# Zevra Therapeutics, Inc.: Form 8-K, filed Apr 7, 2025

- Company: [Zevra Therapeutics, Inc.](/companies/zvra.md) (CIK 1434647)
- Form: 8-K
- Filed: 2025-04-07
- Accepted by EDGAR: Apr 7, 2025, 08:04 ET
- Period: 2025-04-01
- Accession: 0001193125-25-073991
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1434647/000119312525073991/d938703d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1434647/000119312525073991/

## Items reported

- Item 2.01: Completion of an acquisition or disposition
- Item 2.02: Results of operations
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1434647/000119312525073991/d938703d8k.htm

Filed Apr 7, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-073991. Last ingested by Listed: Nov 5, 2026, 14:04 ET. No prices; not investment advice.
